Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension

American Journal of Cardiology - United States
doi 10.1016/j.amjcard.2016.11.066
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Adjusting Droxidopa for Neurogenic Orthostatic Hypotension in a Patient With Parkinson Disease

Clinical Autonomic Research
MedicineEndocrineNeurologyAutonomic Systems
2017English

Neurogenic Orthostatic Hypotension &Ndash; Management Update and Role of Droxidopa

Therapeutics and Clinical Risk Management
2015English

Defining Successful Treatment of Neurogenic Orthostatic Hypotension With Droxidopa in a Patient With Multiple System Atrophy

Clinical Autonomic Research
MedicineEndocrineNeurologyAutonomic Systems
2017English

Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension

Movement Disorders Clinical Practice
Neurology
2017English

Functional Effects of Cardiac Sympathetic Denervation in Neurogenic Orthostatic Hypotension

Parkinsonism and Related Disorders
GerontologyGeriatricsNeurology
2009English

A Practical Guide to the Treatment of Neurogenic Orthostatic Hypotension

Canadian Journal of Neurological Sciences
MedicineNeurology
2014English

Classical and Delayed Orthostatic Hypotension in Patients With Unexplained Syncope and Severe Orthostatic Intolerance

Frontiers in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2020English

Pindolol in Orthostatic Hypotension.

BMJ
1981English

Significance of Orthostatic Hypotension and Severe Cerebral Artery Stenosisin Patients With Stroke of Orthostatic Occurrence.

Nosotchu
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy